File Name: 1_2023-06-27_DelVO_2023_2486_TAXURA_EU.pdf
Converted on: 2025-03-28 03:20:36
Original Size: 8.44 MB
Chunk Size: 800 tokens with 100 tokens overlap
Table Detection: Enabled
--------------------------------------------------------------------------------

Chunk: 123 of 199
--------------------------------------------------------------------------------

(a) the API is a naturally occurring substance, such as vitamins, electrolytes, amino acids, peptides, proteins, nucleotides,
carbohydrates and lipids, and, in line with the European Medicines Agency Guideline on the environmental risk
assessment of medicinal products for human use (EMA ERA guideline) (
1), is generally considered to be degradable in
the environment (2);
(1)European Medicines Agency Guidelines on the environmental risk assessment of medicinal products for human use, version of
27.6.2023 available at: https://www.ema.europa.eu/en/environmental-risk-assessment-medicinal-products-human-use-scientific-
guideline.
(2)Key metabolites are human metabolites likely to be excreted into the environment. Those metabolites are identified in (non-)clinical studies on the metabolism of medicinal products available in the marketing authorisation applications. Such metabolites are to be
identified according to EMA/CPMP/ICH/286/1995, page 8. Key transformation products (TP) of these key human metabolites of the
parent compound (API) are those that exceed 10 % of Dissolved Organic Carbon (DOC) or Total Organic Carbon (TOC) of the parent
compound.OJ L, 21.11.2023 EN